Novel Utilization of Ultrasound Enhancing Agents in Complex Congenital Heart Disease Following Superior Cavopulmonary Connection

Journal of the American Society of Echocardiography - Tập 36 - Trang 516-522 - 2023
Kasey J. Chaszczewski1,2, Jarett R. Linder3,4, Matthew J. Campbell5, Michael Convery6, Yan Wang6, Christopher L. Smith6,7, Benjamin W. Kozyak6,7,8, Michael D. Quartermain6,7
1Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin
2Section of Pediatric Cardiology, The Herma Heart Institute, Milwaukee, Wisconsin
3Division of Pediatric Cardiology, Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois
4Feinberg School of Medicine, Northwestern University, Chicago, Illinois
5Division of Pediatric Cardiology, Nemours Children’s Hospital, Wilmington, Delaware
6Division of Cardiology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
7Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
8Division of Cardiac Critical Care Medicine, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania

Tài liệu tham khảo

McMahon, 2005, Safety and efficacy of intravenous contrast imaging in pediatric echocardiography, Pediatr Cardiol, 26, 413, 10.1007/s00246-004-0795-1 Kutty, 2012, Ultrasound contrast and real-time perfusion in conjunction with supine bicycle stress echocardiography for comprehensive evaluation of surgically corrected congenital heart disease, Eur Heart J Cardiovasc Imaging, 13, 500, 10.1093/ejechocard/jer287 Kutty, 2016, Safety and efficacy of cardiac ultrasound contrast in children and adolescents for resting and stress echocardiography, J Am Soc Echocardiogr, 29, 655, 10.1016/j.echo.2016.02.019 Porter, 2018, Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 American Society of echocardiography guidelines update, J Am Soc Echocardiogr, 31, 241, 10.1016/j.echo.2017.11.013 Gerweck O’Brien, 2009, An empirically based tool for analyzing mortality associated with congenital heart surgery, J Thorac Cardiovasc Surg, 138, 1139, 10.1016/j.jtcvs.2009.03.071 Jacobs, 2013, An empirically based tool for analyzing morbidity associated with operations for congenital heart disease, J Thorac Cardiovasc Surg, 145, 1046, 10.1016/j.jtcvs.2012.06.029 Newburger, 2018, Transplant-free survival and interventions at 6 Years in the SVR trial, Circulation, 137, 2246, 10.1161/CIRCULATIONAHA.117.029375 Galantowicz, 2016, Improved outcomes with the comprehensive stage 2 procedure after an initial hybrid stage 1, J Thorac Cardiovasc Surg, 151, 424, 10.1016/j.jtcvs.2015.10.023 Kurt, 2009, Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort, J Am Coll Cardiol, 53, 802, 10.1016/j.jacc.2009.01.005 Torres, 2017, Contrast-enhanced ultrasound using sulfur hexafluoride is safe in the pediatric setting, Acta Radiol, 58, 1395, 10.1177/0284185117690423 Yusuf, 2017, Retrospective analysis of the safety and cost implications of pediatric contrast-enhanced ultrasound at a single center, Am J Roentgenol, 208, 446, 10.2214/AJR.16.16700 Riccabona, 2012, Application of a second-generation US contrast agent in infants and children—a European questionnaire-based survey, Pediatr Radiol, 42, 1471, 10.1007/s00247-012-2472-5 Lindner, 2002, Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration, J Am Soc Echocardiogr, 15, 396, 10.1067/mje.2002.117290 Kalra, 2014, Perflutren-based echocardiographic contrast in patients with right-to-left intracardiac shunts, JACC Cardiovasc Imaging, 7, 206, 10.1016/j.jcmg.2013.11.003 Kumar, 2019, Safety profile of ultrasound enhancing agents in echocardiography, Echocardiography, 36, 1041, 10.1111/echo.14344